Your browser doesn't support javascript.
Understanding T cell responses to COVID-19 is essential for informing public health strategies.
Vardhana, Santosha; Baldo, Lance; Morice, William G; Wherry, E John.
  • Vardhana S; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Baldo L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morice WG; Parker Institute for Cancer Immunotherapy Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wherry EJ; Adaptive Biotechnologies, Seattle, WA, USA.
Sci Immunol ; 7(71): eabo1303, 2022 05 20.
Article in English | MEDLINE | ID: covidwho-1759271
ABSTRACT
Durable T cell responses to SARS-CoV-2 antigens after infection or vaccination improve immune-mediated viral clearance. To date, population-based surveys of COVID-19 adaptive immunity have focused on testing for IgG antibodies that bind spike protein and/or neutralize the virus. Deployment of existing methods for measuring T cell immunity could provide a more complete profile of immune status, informing public health policies and interventions.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Sci Immunol Year: 2022 Document Type: Article Affiliation country: Sciimmunol.abo1303

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Sci Immunol Year: 2022 Document Type: Article Affiliation country: Sciimmunol.abo1303